Skip to main content
Equibles

CSCI · COSCIENS Biopharma Inc.

Use CSCI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CSCI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
8.50 CAD +0.10 (+1.19%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked
Volume · Nov 6 200 Avg daily vol (3M) 822

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close8.50 CAD Open8.50 CAD Day8.50–8.50 CAD Since split7.05–12.94 CAD Avg vol 30d727 DataJul 2026–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Jul 7, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Jul 7, 2026.

Latest documents

2026
Oct 19
Offering documents SEDAR+
1 offering document
  • Report of exempt distribution excluding Schedule 1 of 45-106F1 1
Sep 21
Offering documents SEDAR+
1 offering document
  • Report of exempt distribution excluding Schedule 1 of 45-106F1 1
All documents

Quarterly results

Revenue Net income Net loss
▲67.9% $2.34M −$1.42M '24 Q2 ▼4.1% $1.87M −$5.75M '24 Q3 ▲98.8% $3.32M −$6.73M '24 Q4* ▼32.6% $1.39M −$3.65M '25 Q1 ▲17.6% $2.75M −$2.70M '25 Q2 ▼20.7% $1.48M −$1.82M '25 Q3 ▼43.4% $1.88M −$2.18M '25 Q4* LATEST ▲36.1% $1.89M $10.76M '26 Q1

* Q4 derived as the full year minus Q1 to Q3.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its range since split · 2026-07-07
Range low 7.05 CAD Now 8.50 CAD · 25% Range high 12.94 CAD
vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Jul 7, 2026; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XTSE:CSCI -3.4% -2.9% — +1.2% —

Exchange listing

Market
XTSE
Ticker
CSCI
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company with tickers: CSCIF

Company

Website
https://www.cosciensbio.com/
Investor relations
https://cosciensbio.com/investors-news/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Latest price

Plus & Pro

Follow CSCI during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.